View in EDS HTML Full Text PDF Full Text

Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab.

Saved in:
Bibliographic Details
Title: Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab.
Authors: Coates LC; University of Oxford, Oxford, UK., Abraham S; National Institute for Health Research/Wellcome CRF, Imperial College Healthcare NHS Trust, London, UK., Tillett W; Royal National Hospital for Rheumatic Diseases, Pharmacy and Pharmacology, University of Bath, Bath, UK., Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle., Ramiro S; Leiden University Medical Center, Leiden, and Zuyderland Medical Center, Heerlen, The Netherlands., Wu T; AbbVie, North Chicago, Illinois., Wang X; AbbVie, North Chicago, Illinois., Pangan AL; AbbVie, North Chicago, Illinois., Song IH; AbbVie, North Chicago, Illinois.
Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Feb; Vol. 74 (2), pp. 259-267. Date of Electronic Publication: 2021 Dec 29.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study
Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32937016
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Coates+LC%22">Coates LC</searchLink>; University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Abraham+S%22">Abraham S</searchLink>; National Institute for Health Research/Wellcome CRF, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Tillett+W%22">Tillett W</searchLink>; Royal National Hospital for Rheumatic Diseases, Pharmacy and Pharmacology, University of Bath, Bath, UK.<br /><searchLink fieldCode="AU" term="%22Mease+PJ%22">Mease PJ</searchLink>; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle.<br /><searchLink fieldCode="AU" term="%22Ramiro+S%22">Ramiro S</searchLink>; Leiden University Medical Center, Leiden, and Zuyderland Medical Center, Heerlen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Wu+T%22">Wu T</searchLink>; AbbVie, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; AbbVie, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Pangan+AL%22">Pangan AL</searchLink>; AbbVie, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Song+IH%22">Song IH</searchLink>; AbbVie, North Chicago, Illinois.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101518086%22">Arthritis care & research</searchLink> [Arthritis Care Res (Hoboken)] 2022 Feb; Vol. 74 (2), pp. 259-267. <i>Date of Electronic Publication: </i>2021 Dec 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%22">John Wiley & Sons </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101518086 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2151-4658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222151464X%22">2151464X </searchLink><i>NLM ISO Abbreviation: </i>Arthritis Care Res (Hoboken) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32937016
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/acr.24442
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 259
    Titles:
      – TitleFull: Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Coates LC
      – PersonEntity:
          Name:
            NameFull: Abraham S
      – PersonEntity:
          Name:
            NameFull: Tillett W
      – PersonEntity:
          Name:
            NameFull: Mease PJ
      – PersonEntity:
          Name:
            NameFull: Ramiro S
      – PersonEntity:
          Name:
            NameFull: Wu T
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Pangan AL
      – PersonEntity:
          Name:
            NameFull: Song IH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2151-4658
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Arthritis care & research
              Type: main
ResultId 1